Medicare Enrolled
Dr. Jeffrey Levin, MD
Neurology · Modesto, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Levin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Levin
Dr. Jeffrey Levin is a neurology specialist in Modesto, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Levin performed 1,559 Medicare services across 1,266 unique beneficiaries.
Between the years covered by Open Payments, Dr. Levin received a total of $22,769 from 75 pharmaceutical and/or device companies across 1079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in CA
$22,769 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,559
Medicare services
Top 23% in CA for neurology
1,266
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
404 | $67 | $183 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
382 | $77 | $203 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
278 | $76 | $226 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
182 | $352 | $941 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
127 | $144 | $362 |
| EEG monitoring for coma or sleep This procedure measures brain wave activity to monitor patients who are in a coma or asleep. |
56 | $45 | $880 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
36 | $111 | $277 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
33 | $279 | $809 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $103 | $257 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
28 | $93 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,769
Total received (2018-2024)
Avg $3,253/year across 7 years
Top 14% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,079
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,327 (98.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$418 (1.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,928
2023
$2,871
2022
$2,521
2021
$3,451
2020
$2,134
2019
$3,857
2018
$3,007
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$2,425
MDD US Operations, LLC
$400
UCB, Inc.
$313
Neurelis, Inc.
$281
Amneal Pharmaceuticals LLC
$182
ACADIA Pharmaceuticals Inc
$169
PFIZER INC.
$156
Alexion Pharmaceuticals, Inc.
$153
Neurocrine Biosciences, Inc.
$98
Eisai Inc.
$80
CSL Behring
$71
Aucta Pharmaceuticals, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$64
Grifols USA, LLC
$59
HOSPIRA, INC.
$48
ARGENX US, INC.
$42
Averitas Pharma Inc.
$40
Otsuka America Pharmaceutical, Inc.
$40
Kyowa Kirin, Inc.
$31
CATALYST PHARMACEUTICALS, INC.
$30
Novartis Pharmaceuticals Corporation
$29
NEUROPACE, INC.
$26
JAZZ PHARMACEUTICALS INC.
$20
Acorda Therapeutics, Inc
$20
Merz Pharmaceuticals, LLC
$20
Kedrion Biopharma, Inc.
$18
Genentech USA, Inc.
$17
ABBVIE INC.
$16
Alnylam Pharmaceuticals Inc.
$15
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$3,894
UCB, Inc.
$1,902
ACADIA Pharmaceuticals Inc
$1,264
Teva Pharmaceuticals USA, Inc.
$931
MDD US Operations, LLC
$676
Sunovion Pharmaceuticals Inc.
$666
Eisai Inc.
$645
Neurocrine Biosciences, Inc.
$629
US WorldMeds, LLC
$607
PFIZER INC.
$571
Supernus Pharmaceuticals, Inc.
$549
Alexion Pharmaceuticals, Inc.
$509
Amneal Pharmaceuticals LLC
$498
Avanir Pharmaceuticals, Inc.
$494
Neurelis, Inc.
$492
Novartis Pharmaceuticals Corporation
$461
Genentech USA, Inc.
$442
Vanda Pharmaceuticals Inc.
$419
Adamas Pharmaceuticals, Inc.
$366
Greenwich Biosciences, Inc.
$338
CSL Behring
$325
AbbVie Inc.
$315
ABBVIE INC.
$289
Acorda Therapeutics, Inc
$276
EISAI INC.
$261
Allergan, Inc.
$260
Otsuka America Pharmaceutical, Inc.
$256
Biohaven Pharmaceutical Holding Company Ltd.
$243
Kyowa Kirin, Inc.
$236
Lundbeck LLC
$212
Biogen, Inc.
$201
GENZYME CORPORATION
$201
SK Life Science, Inc.
$199
Biohaven Pharmaceuticals, Inc.
$194
CATALYST PHARMACEUTICALS, INC.
$185
Grifols USA, LLC
$172
IMPEL PHARMACEUTICALS INC.
$157
AstraZeneca Pharmaceuticals LP
$144
Amgen Inc.
$140
ARGENX US, INC.
$130
Celgene Corporation
$126
Strongbridge US INC.
$125
Lilly USA, LLC
$118
Vertical Pharmaceuticals, LLC
$116
Octapharma USA, Inc.
$111
Bayer HealthCare Pharmaceuticals Inc.
$108
Sumitomo Pharma America, Inc.
$107
Janssen Pharmaceuticals, Inc
$97
EMD Serono, Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$83
Aucta Pharmaceuticals, Inc.
$65
NeuroPace, Inc.
$59
Alnylam Pharmaceuticals Inc.
$58
Averitas Pharma Inc.
$54
MITSUBISHI TANABE PHARMA AMERICA, INC.
$51
HOSPIRA, INC.
$48
Boston Scientific Corporation
$48
AQUESTIVE THERAPEUTICS, INC.
$47
Catalyst Pharmaceuticals, Inc.
$47
NEUROPACE, INC.
$45
Allergan Inc.
$41
PTC Therapeutics, Inc.
$41
Merz Pharmaceuticals, LLC
$40
Upsher-Smith Laboratories LLC
$40
E.R. Squibb & Sons, L.L.C.
$38
JAZZ PHARMACEUTICALS INC.
$38
Mallinckrodt Hospital Products Inc.
$27
Akcea Therapeutics, Inc.
$27
UPSHER-SMITH LABORATORIES LLC
$26
Mitsubishi Tanabe Pharma America, Inc.
$21
Medtronic USA, Inc.
$20
Abbott Laboratories
$18
Kedrion Biopharma, Inc.
$18
Impax Laboratories, Inc.
$14
Sarepta Therapeutics, Inc.
$11
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Albuked · BOTOX · BRILINTA · Banzel · Betaseron · Briviact · COMIRNATY · COPAXONE · DAYBUE · DIVIGEL · DUOPA · EMFLAZA · EMGALITY · EPIDIOLEX · EXONDYS 51 · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL - DBS · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · HYQVIA · Hetlioz · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RNS Neurostimulator Kit · RNS System · RYTARY · Radicava · Rystiggo · SOLIRIS · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART · Vimpat · XADAGO · XARELTO · Xadago · Xeomin · ZAVZPRET · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
22
Per 100K population
4.0
County median income
$79,661
Nearest hospital
DOCTORS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Levin is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Levin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Levin performed 404 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levin receive payments from pharmaceutical companies?
Yes. Dr. Levin received a total of $22,769 from 75 companies across 1,079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levin's costs compare to other neurologists in Modesto?
Dr. Levin's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Modesto
Browse neurologists in Modesto ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology